FDA
-
-
-
-
-
-
-
JAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity
-
-
-
-
-
-
-
NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026
323,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

